Daniel Byrd
Overview
Explore the profile of Daniel Byrd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keswani R, Byrd D, Garcia Vicente F, Heller J, Klug M, Mazumder N, et al.
Endosc Int Open
. 2021 Feb;
9(2):E233-E238.
PMID: 33553586
Storage of full-length endoscopic procedures is becoming increasingly popular. To facilitate large-scale machine learning (ML) focused on clinical outcomes, these videos must be merged with the patient-level data in the...
2.
Li F, Sheng Y, Hou W, Sampath P, Byrd D, Thorne S, et al.
J Immunother Cancer
. 2020 Feb;
8(1).
PMID: 32098828
Background: Natural killer (NK) cells have potent antitumor activities. Nevertheless, adoptive transfer therapy of NK cells has gained very limited success in patients with solid tumors as most infused NK...
3.
Amet T, Lan J, Shepherd N, Yang K, Byrd D, Xing Y, et al.
AIDS Res Hum Retroviruses
. 2016 May;
32(10-11):1100-1112.
PMID: 27231035
Human immunodeficiency virus type 1 (HIV-1) escapes complement-mediated lysis (CML) by incorporating host regulators of complement activation (RCA) into its envelope. CD59, a key member of RCA, is incorporated into...
4.
Meng Z, Du L, Hu N, Byrd D, Amet T, Desai M, et al.
Medicine (Baltimore)
. 2016 Apr;
95(15):e3285.
PMID: 27082567
Autoimmune manifestations are common in human immunodeficiency virus (HIV) patients. However, the autoantibody spectrum associated with HIV infection and the impact of antiretroviral therapy (ART) remains to be determined. The...
5.
Rojas J, Sampath P, Bonilla B, Ashley A, Hou W, Byrd D, et al.
Cell Rep
. 2016 Apr;
15(2):264-73.
PMID: 27050526
The immune response plays a key role in enhancing the therapeutic activity of oncolytic virotherapies. However, to date, investigators have relied on inherent interactions between the virus and the immune...
6.
Yang K, Lan J, Shepherd N, Hu N, Xing Y, Byrd D, et al.
J Virol
. 2015 Jul;
89(18):9393-406.
PMID: 26136568
Unlabelled: Both HIV-1 virions and infected cells use their surface regulators of complement activation (RCA) to resist antibody-dependent complement-mediated lysis (ADCML). Blockage of the biological function of RCA members, particularly...
7.
Lan J, Yang K, Byrd D, Hu N, Amet T, Shepherd N, et al.
J Immunol
. 2014 Aug;
193(7):3577-89.
PMID: 25149467
Latently HIV-1-infected cells are recognized as the last barrier toward viral eradication and cure. To purge these cells, we combined a provirus stimulant with a blocker of human CD59, a...
8.
Byrd D, Shepherd N, Lan J, Hu N, Amet T, Yang K, et al.
J Virol
. 2014 Apr;
88(12):6819-31.
PMID: 24696488
Unlabelled: Human monocytic and professional antigen-presenting cells have been reported only to exhibit abortive infections with vaccinia virus (VACV). We found that monocyte-derived macrophages (MDMs), including granulocyte macrophage colony-stimulating factor...
9.
Hu S, Ghabril M, Amet T, Hu N, Byrd D, Yang K, et al.
PLoS One
. 2014 Feb;
9(2):e86964.
PMID: 24516541
Unlabelled: The pathogenesis of accelerated liver damage in subjects coinfected with hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) remains largely unknown. Recent studies suggest that ongoing...
10.
Byrd D, Amet T, Hu N, Lan J, Hu S, Yu Q
J Virol
. 2013 Jun;
87(16):9301-12.
PMID: 23785200
Poxviruses, including vaccinia virus (VV) and canarypox virus (ALVAC), do not indiscriminately infect all cell types of the primary human leukocytes (PHLs) that they encounter but instead demonstrate an extremely...